Gorgani NN, Kim KHS, Free WL, Afkham M, Henson JD, Shamanna P, Ajdari S, Kahn CR, Hirst TR, Barnett AH, Paul SK. OZ101, an oligofructose prebiotic, may prolong sulphonylurea efficcy in patients with type 2 diabetes: a pilot study: OZ101 and sulphonylurea-mediated glycaemic control. J Current Med Res Opinion [Internet]. 2022 Jun. 22 [cited 2024 May 20];5(06):1235-51. Available from: https://cmro.in/index.php/jcmro/article/view/528